434 related articles for article (PubMed ID: 8396526)
1. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
[TBL] [Abstract][Full Text] [Related]
2. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
Hayden MK; Koenig GI; Trenholme GM
Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
[TBL] [Abstract][Full Text] [Related]
4. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
Neudorfer K; Schmidt-Malan SM; Patel R
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients.
Wiland AM; Plaisance KI; Schwalbe RS
Pharmacotherapy; 1994; 14(1):89-94. PubMed ID: 8159604
[TBL] [Abstract][Full Text] [Related]
6. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
8. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
12. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.
el-Mady A; Mortensen JE
Diagn Microbiol Infect Dis; 1991; 14(2):141-5. PubMed ID: 1651825
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Baltch AL; Smith RP; Ritz WJ; Bopp LH
Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
15. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
[TBL] [Abstract][Full Text] [Related]
16. Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1993; 39(4):248-53. PubMed ID: 8325126
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Messick CR; Woodward J; Pendland SL
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility patterns of enterococci causing infections.
Oncu S; Punar M; Eraksoy H
Tohoku J Exp Med; 2004 Jan; 202(1):23-9. PubMed ID: 14738321
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.
Simonsen GS; Småbrekke L; Monnet DL; Sørensen TL; Møller JK; Kristinsson KG; Lagerqvist-Widh A; Torell E; Digranes A; Harthug S; Sundsfjord A
J Antimicrob Chemother; 2003 Feb; 51(2):323-31. PubMed ID: 12562698
[TBL] [Abstract][Full Text] [Related]
20. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs.
Ferrara A; Dos Santos C; Cimbro M
Chemotherapy; 1996; 42(1):37-46. PubMed ID: 8751265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]